Intravenous-to-Oral Conversion Therapy for Antimicrobials

Intravenous-to-Oral Conversion Therapy for Antimicrobials

Saved in:

Bibliographic Details
Main Authors:	John M Conly, Stephen D Shafran
Format:	Article
Language:	English
Published:	Wiley 1994-01-01
Series:	Canadian Journal of Infectious Diseases
Online Access:	http://dx.doi.org/10.1155/1994/428375
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Intravenous to Oral Antimicrobial Stepdown Therapy at the Henderson Hospital, Hamilton, Ontario
by: LA Mandell, et al.
Published: (1995-01-01)

Prospective, Randomized Comparison of Intravenous and Oral Ciprofloxacin with Intravenous Ceftazidime in the Treatment of Nosocomial Pneumonia
by: Raphael Saginur, et al.
Published: (1997-01-01)

Current Practice and Barriers to an Early Antimicrobial Conversion from Intravenous to Oral among Hospitalized Patients at Jimma University Specialized Hospital: Prospective Observational Study
by: Alemseged Beyene Berha, et al.
Published: (2019-01-01)

Intravenous to Oral Antimicrobial Stepdown Implementation at the Calgary General Hospital, Calgary, Alberta
by: L Heule, et al.
Published: (1995-01-01)

Pharmaceutical, Pharmacokinetic and Other Considerations for Intravenous to Oral Stepdown Therapy
by: Peter J Jewesson
Published: (1995-01-01)

Creutzfeldt-Jakob Disease, New Variant Creutzfeldt-Jakob Disease and Bovine Spongiform Encephalopathy – An Update
by: John M Conly, et al.
Published: (1997-01-01)

Treatment of Cytomegalovirus Retinitis: A Growing Number of Options
by: Stephen D Shafran, et al.
Published: (1996-01-01)

Targeted Versus Universal Vaccination against Hepatitis B: A Paradigm Shift
by: John M Conly, et al.
Published: (1993-01-01)

Transition from Intravenous Epoprostenol to Oral or Subcutaneous Therapy in Pulmonary Arterial Hypertension: A Retrospective Case Series and Systematic Literature Review
by: Kirily Park, et al.
Published: (2011-01-01)

Antimicrobial Resistance in Canada: Update on Activities of the Canadian Committee on Antibiotic Resistance
by: John Conly
Published: (2002-01-01)

Antimicrobial Resistance in Canada: An Update on Activities of the Canadian Committee on Antibiotic Resistance
by: John Conly
Published: (2001-01-01)

Intravenous to Oral Stepdown Antibiotic Therapy: Another Cost-Effective Strategy in an Era of Shrinking Health Care Dollars
by: Thomas J Louie
Published: (1994-01-01)

Conversion of Intermediate Therapies into Intensive Therapies.
by: Rubén Bembibre Taboada, et al.
Published: (2006-04-01)

Differences in catheter-related complications to insertion site selection for long peripheral intravenous catheters in antimicrobial therapy: a randomized controlled trial
by: Linfang Zhao, et al.
Published: (2025-02-01)

Implementation and evaluation of a complex outpatient oral antimicrobial therapy program (COpAT) in Canada
by: Maggie Wong, et al.
Published: (2025-01-01)

Neurological Crisis Following Intravenous Ozone Therapy; a Case Report
by: Chloe Y Y Wong, et al.
Published: (2025-01-01)

Outpatient Intravenous Antibiotic Therapy: The Vancouver Hospital experience
by: Grant Stiver, et al.
Published: (2000-01-01)

Effectiveness of Antiviral Treatment with Intravenous Peramivir and Oral Oseltamivir for Seasonal Influenza in Children
by: Young-hoon Byun, et al.
Published: (2024-12-01)

Analysis of the practice of switch of antibiotics from intravenous to oral therapy at a tertiary care hospital in Nepal: a prospective observational study
by: Upasana Acharya, et al.
Published: (2025-01-01)

Reducing Antibiotic Costs: The Ottawa General Hospital Experience of Cost Cutting, Including Intravenous to Oral Stepdown
by: GE Garber, et al.
Published: (1995-01-01)

A B C D E F G ...
by: SD Shafran, et al.
Published: (1996-01-01)

The Scourge of Tuberculosis Revisited
by: JM Conly, et al.
Published: (1995-01-01)

Current Issues and Perspectives: Prevention of Central Venous Catheter Infections
by: JM Conly, et al.
Published: (1992-01-01)

Pseudo-, Xantho-, and now Stenotrophomonas maltophilia: New Kid on the Block
by: JM Conly, et al.
Published: (1996-01-01)

‘Big MAC’ Attack
by: SD Shafran, et al.
Published: (1993-01-01)

The Cost of Health Care for AIDS Patients in Saskatchewan
by: Kevin P Browne, et al.
Published: (1990-01-01)

Riboflavin- and Hypericin-Mediated Antimicrobial Photodynamic Therapy as Alternative Treatments for Oral Candidiasis: A Systematic Review
by: Maciej Łopaciński, et al.
Published: (2024-12-01)

Comparative Pharmacokinetics of Levofloxacin in Healthy and Renal Damaged Muscovy Ducks following Intravenous and Oral Administration
by: Mohamed Aboubakr, et al.
Published: (2014-01-01)

The Sanford Guide to Antimicrobial Therapy /
Published: (2007)

Erratum to “Comparative Pharmacokinetics of Levofloxacin in Healthy and Renal Damaged Muscovy Ducks following Intravenous and Oral Administration”
by: Mohamed Aboubakr, et al.
Published: (2014-01-01)

Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves’ Orbitopathy
by: Hiroyuki Eguchi, et al.
Published: (2015-01-01)

The Effects of Preoperative Oral Pregabalin and Perioperative Intravenous Lidocaine Infusion on Postoperative Morphine Requirement in Patients Undergoing Laparatomy
by: Senniye Ulgen Zengin, et al.
Published: (2015-01-01)

Antimicrobial Effects of Gum Arabic-Silver Nanoparticles against Oral Pathogens
by: Omnia Ahmed, et al.
Published: (2022-01-01)

Ambulatory Intravenous Antibiotic Therapy in Quebec: The Hôpital Charles LeMoyne Experience in 1996
by: Laurent Delorme, et al.
Published: (2000-01-01)

Bacteriophages: A Challenge for Antimicrobial Therapy
by: Nallelyt Segundo-Arizmendi, et al.
Published: (2025-01-01)

Mycobacterium avium Complex: Current Management
by: Stephen D Shafran
Published: (1994-01-01)

Community Intravenous Therapy Program and a Treatment Plan for Foot Infections in Persons with Diabetes: A Clinical Perspective
by: John M Embil, et al.
Published: (2000-01-01)

Conversion Disorder: Early Diagnosis and Personalized Therapy Plan Is the Key
by: Lauren Miller, et al.
Published: (2020-01-01)

The Hepatitis C Genotype 1 Paradox: Cost per Treatment Is Increasing, but Cost per Cure Is Decreasing
by: Stephen D Shafran
Published: (2015-01-01)

Response to: Comment on “Hepatitis C and the Sex Trade”
by: Stephen D. Shafran
Published: (2016-01-01)